Insys Therapeutics Competitors and Similar CompaniesClear all
Insys Therapeutics's competitors and similar companies include Assertio, AstraZeneca and BeyondSpring.
 Insys Therapeutics Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative supportive care products. |  Assertio Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. | |
Founding Date | Founding Date 1998 | Founding Date 1995 | Founding Date 1999 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Chandler, US HQ Chandler, US Round Rock, US | Locations Lake Forest, US HQ | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations Florham Park, US HQ |
Employees | Employees 22634% decrease | Employees 3058% increase | Employees 94,300 | Employees 4014% increase |
Valuation ($) | Valuation ($) 3.1 m | Valuation ($) 104.9 m | Valuation ($) 2.7 b | Valuation ($) 89.4 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $82.1m (FY, 2018) | Revenue (est.) $118.7m (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $10.8m (FY, 2018) | Cost of goods N/A | Cost of goods $4.9b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $71.3m (FY, 2018) | Gross profit N/A | Gross profit $54.2b (FY, 2025) | Gross profit N/A |
Net income | Net income ($124.5m) (FY, 2018) | Net income ($30.4m) (FY, 2025) | Net income $10.2b (FY, 2025) | Net income ($16.7m) (FY, 2024) |
Operating ⚠ | ||||
Patents (US) | Patents (US) N/A | Patents (US) 12 (FY, 2020) | Patents (US) N/A | Patents (US) 20 (Mar, 2020) |
Funding | ||||
Total funding raised | Total funding raised $ 2.3m | Total funding raised $ 42.5m | Total funding raised $ 1b | Total funding raised $ 36.1m |
For sources of this data, please see the company profile
View Company Profiles
Assertio
HQ
Lake Forest, US
Employees
30
Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View companyBeyondSpring
HQ
Florham Park, US
Employees
40↑ 14% increase
BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
View company